Page 159 - 南京医科大学自然科学版第1期

第41卷第1期 王宇昊，王增军. 非编码RNA与肾细胞癌对舒尼替尼敏感性关系的研究进展［J］.
2021年1月 南京医科大学学报（自然科学版），2021，41（01）：149-153 ·153 ·

regulation of cell signaling in cancer［J］. Oncogene， ［34］ TIEN A H，SADAR M D. Keys to unlock androgen recep⁃
2017，36（41）：5661-5667 tor translocation［J］. J Biol Chem，2019，294（22）：8711-
［20］ TAY Y，RINN J，PANDOLFI P P. The multilayered com⁃ 8712
plexity of ceRNA crosstalk and competition［J］. Nature， ［35］BERKERS J，GOVAERE O，WOLTER P，et al. A possi⁃
2014，505（7483）：344-352 ble role for microRNA⁃141 down⁃regulation in sunitinib
［21］ BHAN A，SOLEIMANI M，MANDAL S S. Long noncod⁃ resistant metastatic clear cell renal cell carcinoma
ing RNA and cancer：a new paradigm［J］. Cancer Res， through induction of epithelial⁃to⁃mesenchymal transition
2017，77（15）：3965-3981 and hypoxia resistance［J］. J Urol，2013，189（5）：1930-
［22］ SUN Z，SHI K，YANG S，et al. Effect of exosomal miRNA 1938
on cancer biology and clinical applications［J］. Mol Can⁃ ［36］ VANDAMME N，DENECKER G，BRUNEEL K，et al. The
cer，2018，17（1）：147 EMT transcription factor ZEB2 promotes proliferation of
［23］ LEI M，ZHENG G，NING Q，et al. Translation and func⁃ primary and metastatic melanoma while suppressing an
tional roles of circular RNAs in human cancer［J］. Mol invasive，mesenchymal⁃like phenotype［J］. Cancer Res，
Cancer，2020，19（1）：30 2020，80（14）：2983-2995
［24］ YU T，WANG Y，FAN Y，et al. CircRNAs in cancer me⁃ ［37］ ZHANG D D，LI Y，XU Y，et al. Phosphodiesterase 7B/mi⁃
tabolism：a review［J］. J Hematol Oncol，2019，12（1）：90 croRNA ⁃ 200c relationship regulates triple ⁃ negative
［25］ RUPAIMOOLE R，SLACK F J. MicroRNA therapeutics： breast cancer cell growth［J］. Oncogene，2019，38（7）：
towards a new era for the management of cancer and other 1106-1120
diseases［J］. Nat Rev Drug Discov，2017，16（3）：203-221 ［38］ PRIOR C，PEREZ⁃GRACIA J L，GARCIA⁃DONAS J，et
［26］ QIAN X，ZHAO J，YEUNG P Y，et al. Revealing lncRNA al. Identification of tissue microRNAs predictive of suni⁃
structures and interactions by sequencing ⁃ based ap⁃ tinib activity in patients with metastatic renal cell carcino⁃
proaches［J］. Trends Biochem Sci，2019，44（1）：33-52 ma［J］. PLoS One，2014，9（1）：e86263
［27］ LI X，YANG L，CHEN L L. The biogenesis，functions， ［39］ KHELLA H，BUTZ H，DING Q，et al. miR⁃221/222 are
and challenges of circular RNAs［J］. Mol Cell，2018，71 involved in response to sunitinib treatment in metastatic
（3）：428-442 renalcellcarcinoma［J］. Mol Ther，2015，23（11）：1748-1758
［28］ QU L，DING J，CHEN C，et al. Exosome⁃transmitted ln⁃ ［40］ GOTO Y，KUROZUMI A，NOHATA N，et al. The microR⁃
cARSR promotes sunitinib resistance in renal cancer by NA signature of patients with sunitinib failure：regulation
acting as a competing endogenous RNA［J］. Cancer Cell， of UHRF1 pathways by microRNA⁃101 in renal cell carci⁃
2016，29（5）：653-668 noma［J］. Oncotarget，2016，7（37）：59070-59086
［29］ VILLARROYA⁃BELTRI C，GUTIÉRREZ⁃VÁZQUEZ C， ［41］ XIAO W，LOU N，RUAN H L，et al. Mir⁃144⁃3p promotes
SÁNCHEZ⁃CABO F，et al. Sumoylated hnRNPA2B1 con⁃ cell proliferation，metastasis，sunitinib resistance in clear
trols the sorting of miRNAs into exosomes through bind⁃ cell renal cell carcinoma by downregulating ARID1A［J］.
ing to specific motifs［J］. Nat Commun，2013，4：2980 Cell Physiol Biochem，2017，43（6）：2420-2433
［30］ HE D，LI L，ZHU G，et al. ASC⁃J9 suppresses renal cell ［42］ MERHAUTOVA J，HEZOVA R，POPRACH A，et al. miR
carcinoma progression by targeting an androgen receptor⁃ ⁃155 and miR⁃484 are associated with time to progression
dependent HIF2α/VEGF signaling pathway［J］. Cancer in metastatic renal cell carcinoma treated with sunitinib
Res，2014，74（16）：4420-4430 ［J］. Biomed Res Int，2015，2015：941980
［31］ ADELAIYE⁃OGALA R，DAMAYANTI N P，ORILLION ［43］ YAMAGUCHI N，OSAKI M，ONUMA K，et al. Identifica⁃
A R，et al. Therapeutic targeting of sunitinib⁃induced AR tion of microRNAs involved in resistance to sunitinib in
phosphorylation in renal cell carcinoma［J］. Cancer Res， renal cell carcinoma cells［J］. Anticancer Res，2017，37
2018，78（11）：2886-2896 （6）：2985-2992
［32］ ZHAI W，SUN Y，GUO C，et al. LncRNA⁃SARCC sup⁃ ［44］ LI J，HUANG C，ZOU Y，et al. CircTLK1 promotes the
presses renal cell carcinoma（RCC）progression via alter⁃ proliferation and metastasis of renal cell carcinoma by
ing the androgen receptor（AR）/miRNA⁃ 143⁃3p signals sponging miR⁃136⁃5p［J］. Mol Cancer，2020，19（1）：103
［J］. Cell Death Differ，2017，24（9）：1502-1517 ［45］ LIU H，HU G，WANG Z，et al. circPTCH1 promotes inva⁃
［33］ DAGAR M，SINGH J P，DAGAR G，et al. Phosphoryla⁃ sion and metastasis in renal cell carcinoma via regulating
tion of HSP90 by protein kinase A is essential for the nu⁃ miR ⁃ 485 ⁃ 5p/MMP14 axis［J］. Theranostics，2020，10
clear translocation of androgen receptor［J］. J Biol Chem， （23）：10791-10807
2019，294（22）：8699-8710 ［收稿日期］ 2019-12-06